Cargando…

The development of an instrument to predict patients’ adoption of mHealth in the developing world

INTRODUCTION: There are many tools for measuring patient’s potential adoption of mHealth (i.e. mobile health) in the developed world, but none of these instruments provides a comprehensive means for measuring critical issues affecting the adoption of mHealth by patients in the developing world. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Addotey-Delove, Michael, Scott, Richard E., Mars, Maurice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479692/
https://www.ncbi.nlm.nih.gov/pubmed/36119636
http://dx.doi.org/10.1016/j.imu.2022.100898
_version_ 1784790847714230272
author Addotey-Delove, Michael
Scott, Richard E.
Mars, Maurice
author_facet Addotey-Delove, Michael
Scott, Richard E.
Mars, Maurice
author_sort Addotey-Delove, Michael
collection PubMed
description INTRODUCTION: There are many tools for measuring patient’s potential adoption of mHealth (i.e. mobile health) in the developed world, but none of these instruments provides a comprehensive means for measuring critical issues affecting the adoption of mHealth by patients in the developing world. The aim of this paper was to develop a valid and reliable assessment instrument for predicting mHealth adoption by patients in the developing world. METHOD: A Patients mHealth Technology Adoption Questionnaire (PmTAQ) was developed based on themes identified through a prior published structured literature review of factors affecting patients’ mHealth adoption in the developing world, from which eight constructs evolved. Face and content validity was confirmed by 15 mothers who had used mHealth (the Mobile Technology for Community Health (MoTeCH) service) for maternal care, and the findings were used to improve the instrument. To assess the validity and reliability of the instrument at least 64 mothers who used MoTeCH were randomly selected from each of nine clusters of health posts in one district in Ghana. The assessment instrument consisted of 39 items, categorised under eight components: Cost and ownership, user characteristics, language and literacy, infrastructure, collaboration and funding, governance, system utility, and intention to adopt. Exploratory and confirmatory factor analysis were performed. RESULTS: The data from 585 mothers were analysed. Exploratory factor analysis showed the eigenvalue of all eight components to be significant (cumulative total greater than 1.0). Bartlett’s test of sphericity was significant, the Kaiser-Meyer-Olkin value was 0.84 and the mean Cronbach’s α value was 0.82 (range 0.81–0.83). The components were found to be valid. Confirmatory factor analysis showed that all indices for the measurement model were within acceptable limit leading to the use of structural equation modelling to show the causal relationship between components, resulting in the development of the mHealth Adoption Impact Model (mAIM). The mAIM shows a strong relationship between latent constructs for patients’ mHealth adoption. CONCLUSION: The study presents an evidence-based, reliable and valid instrument and model for application in future research, policy development, and implementations related to patient mHealth adoption in the developing world.
format Online
Article
Text
id pubmed-9479692
institution National Center for Biotechnology Information
language English
publishDate 2022
record_format MEDLINE/PubMed
spelling pubmed-94796922022-09-16 The development of an instrument to predict patients’ adoption of mHealth in the developing world Addotey-Delove, Michael Scott, Richard E. Mars, Maurice Inform Med Unlocked Article INTRODUCTION: There are many tools for measuring patient’s potential adoption of mHealth (i.e. mobile health) in the developed world, but none of these instruments provides a comprehensive means for measuring critical issues affecting the adoption of mHealth by patients in the developing world. The aim of this paper was to develop a valid and reliable assessment instrument for predicting mHealth adoption by patients in the developing world. METHOD: A Patients mHealth Technology Adoption Questionnaire (PmTAQ) was developed based on themes identified through a prior published structured literature review of factors affecting patients’ mHealth adoption in the developing world, from which eight constructs evolved. Face and content validity was confirmed by 15 mothers who had used mHealth (the Mobile Technology for Community Health (MoTeCH) service) for maternal care, and the findings were used to improve the instrument. To assess the validity and reliability of the instrument at least 64 mothers who used MoTeCH were randomly selected from each of nine clusters of health posts in one district in Ghana. The assessment instrument consisted of 39 items, categorised under eight components: Cost and ownership, user characteristics, language and literacy, infrastructure, collaboration and funding, governance, system utility, and intention to adopt. Exploratory and confirmatory factor analysis were performed. RESULTS: The data from 585 mothers were analysed. Exploratory factor analysis showed the eigenvalue of all eight components to be significant (cumulative total greater than 1.0). Bartlett’s test of sphericity was significant, the Kaiser-Meyer-Olkin value was 0.84 and the mean Cronbach’s α value was 0.82 (range 0.81–0.83). The components were found to be valid. Confirmatory factor analysis showed that all indices for the measurement model were within acceptable limit leading to the use of structural equation modelling to show the causal relationship between components, resulting in the development of the mHealth Adoption Impact Model (mAIM). The mAIM shows a strong relationship between latent constructs for patients’ mHealth adoption. CONCLUSION: The study presents an evidence-based, reliable and valid instrument and model for application in future research, policy development, and implementations related to patient mHealth adoption in the developing world. 2022 2022-03-05 /pmc/articles/PMC9479692/ /pubmed/36119636 http://dx.doi.org/10.1016/j.imu.2022.100898 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ).
spellingShingle Article
Addotey-Delove, Michael
Scott, Richard E.
Mars, Maurice
The development of an instrument to predict patients’ adoption of mHealth in the developing world
title The development of an instrument to predict patients’ adoption of mHealth in the developing world
title_full The development of an instrument to predict patients’ adoption of mHealth in the developing world
title_fullStr The development of an instrument to predict patients’ adoption of mHealth in the developing world
title_full_unstemmed The development of an instrument to predict patients’ adoption of mHealth in the developing world
title_short The development of an instrument to predict patients’ adoption of mHealth in the developing world
title_sort development of an instrument to predict patients’ adoption of mhealth in the developing world
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479692/
https://www.ncbi.nlm.nih.gov/pubmed/36119636
http://dx.doi.org/10.1016/j.imu.2022.100898
work_keys_str_mv AT addoteydelovemichael thedevelopmentofaninstrumenttopredictpatientsadoptionofmhealthinthedevelopingworld
AT scottricharde thedevelopmentofaninstrumenttopredictpatientsadoptionofmhealthinthedevelopingworld
AT marsmaurice thedevelopmentofaninstrumenttopredictpatientsadoptionofmhealthinthedevelopingworld
AT addoteydelovemichael developmentofaninstrumenttopredictpatientsadoptionofmhealthinthedevelopingworld
AT scottricharde developmentofaninstrumenttopredictpatientsadoptionofmhealthinthedevelopingworld
AT marsmaurice developmentofaninstrumenttopredictpatientsadoptionofmhealthinthedevelopingworld